Formulation and Drug Delivery

Improving Solubility of Cannabinoids

February 02, 2020

Lipid-based solutions offer a natural approach to improving the solubility of cannabinoid-derived products.

Quantitative Rupture Testing of Soft Gelatin Capsules: Understanding Aberrant Results

February 02, 2020

This paper discusses what causes cross-linking, how cross-linking is addressed with addition of enzymes, and consideration for occasional high results that can be obtained during release testing.

More Capacity and Technology Translate to More Options

February 01, 2020

The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.

Daiichi Sankyo Licenses ERS Genomics’ CRISPR Gene Editing Tech

January 31, 2020

Pharmaceutical Technology's In the Lab eNewsletter

The license gives Daiichi Sankyo access to ERS Genomics’ genome-editing technology for internal R&D initiatives.

Otsuka, PhoreMost Team Up for Drug Discovery

January 31, 2020

Pharmaceutical Technology's In the Lab eNewsletter

Otsuka will use PhoreMost’s phenotypic screening platform to identify new targets for drug development, with a focus on gene therapy.

Johnson & Johnson to Develop a Vaccine Candidate Against Novel Coronavirus

January 30, 2020

J&J’s Janssen Pharmaceutical Companies seeks to develop a vaccine candidate against the novel coronavirus.

FDA Promotes Gene Therapy with New Guidance Documents

January 28, 2020

The agency has published seven guidance documents directed at the development and manufacture of gene therapies.

Eli Lilly to Invest $470 Million into New Pharma Manufacturing Facility

January 27, 2020

The facility will produce parenteral products and delivery devices and is set to create 460 new jobs.

Guidance Explains User Fee Structure for Biosimilars

January 23, 2020

The FDA guidance provides an explanation of changes to user fees under the Biosimilar User Fee Amendments of 2017 under Title IV of the FDA Reauthorization Act of 2017.

GE Builds Single-Use Kit Manufacturing Facility in Switzerland

January 21, 2020

GE Healthcare Life Sciences’ new facility for cell and gene processing supplies will be open in 2022.